Reversing Heart Failure: Where immunology meets cardiology

A fascinating step forward in Nature—where immunology meets cardiology. 🧬❤️   This study shows that engineered dendritic cells can locally reprogram the immune response, reduce fibrosis, and improve cardiac function—without systemic immunosuppression.   The insight is simple, yet profound: 👉 Heart failure is not just hemodynamic—it is immunologic.   From FAP-targeted delivery to checkpoint-mediated tolerance (PD-L1, CTLA4-Ig, IL-10), this work opens the door to a new therapeutic paradigm—precision immunotherapy for heart failure. 🚀   The seeds of reversal may lie not in drugs alone—but in cells that teach the immune system to heal. 🌱 @HFSA